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and females had almost similar travel time of 2.43 and 2.40 minutes, respectively 
(p= 0.80). Travel time was 2.44 minutes for the patients younger than 65 years and 
2.28 minutes for patients older than 65 years (p= 0.25). CONCLUSIONS: There was 
no major difference in access to pharmacy based on age or gender. Blacks have 
statistically significantly shorter travel time than whites. Future work will examine 
other factors like socioeconomic status.
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OBJECTIVES: The aim of the analysis was to compare the medicines centrally 
authorised by EMA with reference to their reimbursement in Poland. In Poland, inno-
vative drugs need to be recommended by Agency for Health Technology Assessment 
(AOTM) before the decision about reimbursement is taken by Minister of Health. 
Recommendations issued by AOTM have been based on Manufacturer`s submis-
sion and additional officially published data, including EMA’s data. METHODS: All 
decisions issued by EMA since 1995 connected with new medicines registration 
were analyzed and categorized into therapeutic area. Then it was checked which 
of the drugs found in the EMA’s database were reimbursed in Poland in the years 
2012- 2013. RESULTS: It was found that till the end of December 2014 there were 563 
unique active substance available in EMA’s database. The analysis shows that in 2012 
the reimbursement in Poland was related to 114 active substances registered in EMA, 
which is approx. 20% of all substances in the EMA’s database. A year later 3% (23%) 
more active substances (131) were reimbursed in Poland. Most active substances 
registered in EMA and reimbursed in Poland, belongs to the group ATC: L (antineo-
plastic and immunomodulating medicines). Over 40% of the active ingredients of 
this group registered in EMA were reimbursed in Poland in 2012 and 50% in 2013. 
The second ATC group was A (alimentary tract and metabolism) -12% and group 
B (blood and blood forming organs) -11% (in both years). CONCLUSIONS: Not all 
drugs registered in EMA are reimbursed in Poland. We can conclude that anticancer 
drugs are the most likely to be paid from public sources, then medicines related to 
treatment metabolism and blood disorders. It was found that there was any drug 
reimbursed in Poland registered by EMA in ATC group P (antiparasitic products, 
insecticides and repellents).
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OBJECTIVES: Access to medicines (ATM) is a key component in enabling and meas-
uring the performance of health systems. This study aims to determine, through a 
systematic literature review, the profile of studies and the results of ATM’s indicators 
in Brazil, according with the dimensions of access proposed by Penchansky and 
Thomas METHODS: A systematic review of observational studies was performed 
using articles located in PUBMED, CENTRAL, LILACS and Essential Medicines and 
Health Products Information Portal (WHO) databases (accessed July 2014), in manual 
search and in grey literature. The methodological quality was assessed using the 
Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies of 
NIH (National Institute of Health - USA). RESULTS: 1482 studies were found and 
28 were included. Among these, 64% evaluated access at the municipal level, 75% 
in the public sector, 50% from the perspective of users, 75% the access to essential 
medicines, 50% evaluated more than one dimension, 82% had indicators related 
to availability. Among all dimensions of ATM 18 different indicators were found. 
The indicator with the greatest utilization rate physical availability (PA) was used 
in 39% of the studies. The results of the indicators were variable, ranged from 30 to 
90.2% for PA and from 2.02 to 18.7 for Median Price Ratio, for example. The quality of 
studies included was considered adequate. CONCLUSIONS: Most of ATM studies in 
Brazil evaluated it in the public sector, assessing essential drugs and using as a data 
source the users. The studies had focus on availability and no studies have assessed 
all dimensions of ATM. The access level was variable between studies. This review 
raises the need to develop a guideline to evaluate ATM that foment comparisons 
and evaluations of the health systems performance through the time.
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AcountAble cAre orgAnizAtions- An econoMic solution to Provide 
QuAlity HeAltHcAre for MedicAre PAtients
Patel P.H.
University of the Sciences, philadelphia, PA, USA
OBJECTIVES: Accountable Care Organizations (ACOs) are groups of doctors, hos-
pitals, and other health care providers, who come together voluntarily to give 
coordinated high quality care to their Medicare patients. The objective is to under-
stand how the policy development and implementation is helping to solve the cost 
and quality of the fragmented U.S. healthcare system. METHODS: Knovner and 
Knickman (2011) textbook on Healthcare delivery in the United States elaborates 
on the major issues and concerns facing the U.S. healthcare system was used to 
evaluate the policy perspective and CMS published data was used to compare the 
performance of ACOs. RESULTS: ACO was able to deal with all the major issues 
and concerns pointed by Knovner and Knickman(2011) in the policy perspective. 
CMS published data shows that 360 Medicare ACOs has been established serving 
5.6 million Americans. ACOs in Pioneer ACO model and Medicare Shared Savings 
Program (MSSP) generated over $417 million in savings for Medicare. Quality of Care 
and Patient experience showed improvements in 28 of the 33 quality measures and 
30 of 33 quality measures in Pioneer and MSSP ACOs. Only 3 Pioneer ACO and 1 MSSP 
generated shared losses. CONCLUSIONS: The new program has tried to learn from 
strategies to improve the current PP in Pakistan are warranted. Additionally, there 
is a great need of patient educational programs regarding polypharmacy and the 
treatment they receive. Furthermore, additional studies should be undertaken in 
other provinces of Pakistan in order to understand the country level clinicians’ 
prescribing practices.
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OBJECTIVES: This study was aimed to know patients’ awareness and knowledge 
about herbal medicines and their Adverse Drug Reactions (ADRs). METHODS: 322 
patients were asked to give responses to the questionnaire which was developed, 
structured and validated. Random convenience sampling method was used for 
selecting the sample size. The study was conducted in Manipal, Karnataka, India. 
The data was evaluated using SPSS and represented in the form of numbers and per-
centages. RESULTS: 96 patients who have not used herbal medicines were excluded 
from the study. Majority of the patients’ were in the age group of 25-44 (46.3%) 
years and 45-64 (38.8%) years out of which males (54.3%) outnumbered females 
(45.7%). Majority of them were using ayurvedic medicines (24.5%) and combination 
(37%), allopathic and herbal medicines. Reasons behind usage of herbal medicines 
were, more efficacious and lesser side effects (34.07%) and followed by safer than 
conventional drugs (26.54%). Only 39.39% were having knowledge on dose, dura-
tion of therapy, side effects and drug interactions. Main sources of information 
about herbal medicines were found to be friends (32.74%) and drug advertisements 
(32.30%). Of 226 respondents only 65 (28.76%) of them could identify or felt ADRs. 
Out of 65, only 16 of them have reported to physician and 49 patients have taken 
their own decision.18 respondents chosen an alternative therapy, 14 stopped the 
medication, 9 and 8 reduced dosage without consultation and continued medica-
tion respectively. CONCLUSIONS: Overall the respondents of this study were using 
either herbal or combination medicines because they were considered as efficacious 
and have lesser side effects. However, their knowledge related to dose, duration of 
therapy, side effects and drug interaction was less. They were also less aware or 
couldn’t identify ADRs and the ones who were aware about the ADRs, decisions 
taken by them were found to be inappropriate.
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OBJECTIVES: The objective of this study was to evaluate access to healthcare provid-
ers before and after a significant increase in managed care (MC) enrollment in the 
Mississippi Medicaid program. METHODS: A retrospective analysis was conducted 
using Mississippi Medicaid fee-for-service (FFS) and MC pharmacy claims data in the 
period one year prior to (pre-period) and one year after (post-period) the December 
2012 Medicaid MC expansion. Beneficiaries had to be enrolled for at least one month 
during the study period to be included in the analysis. Providers were considered 
to be participating in a plan (FFS or MC) during each observation period if at least 
one pharmacy claim bearing his/her Medicaid provider identity number was filed 
during the period. Distance from beneficiary to provider was calculated by comput-
ing geocodes for their respective zip-codes using the PROC GEOCODE procedure in 
SAS. RESULTS: Overall, the average distance beneficiaries had to travel to see the 
three closest primary care providers (PCPs) or specialists who accept either FFS or 
Medicaid MC plans did not change significantly from the pre- to the post-period (10.2 
miles for PCPs and 7.7 miles for specialist). During the post-period in rural areas, 
beneficiaries in MC had slightly lower distances for PCPs (10.6 miles for MC and 
10.9 for FFS) and for specialist (8.6 miles for MC and 8.9 miles for FFS). Overall, the 
ratio of the number of enrollees per PCP significantly decreased for FFS (p< 0.01) and 
significantly increased for MC plan A and B (p< 0.01). The number of enrollees per 
specialist did not significantly change for FFS (p= 0.059) and significantly increased 
for MC plan A and B (p< 0.01) from the pre- to the post-period. CONCLUSIONS: 
Expansion of Medicaid MC has not adversely affected physician participation in 
Medicaid and in rural areas has slightly improved access to PCPs and specialists.
PHP46
geogrAPHicAl Accessibility to coMMunity And HosPitAl PHArMAcies 
in HAMilton county
Gangal N.S., Widener M., Kelton C., Heaton P.C.
University of Cincinnati, Cincinnati, OH, USA
OBJECTIVES: It is unknown if timely access to pharmacies differs based on demo-
graphic characteristics. The objective of this study was to determine if disparities 
exist in geographical accessibility to community and hospital pharmacies among 
patients in Hamilton County. METHODS: The Ohio State Board of Pharmacy pro-
vided a list of all the pharmacies in Hamilton County Ohio. The geographic distribu-
tion of the population in each census block group was based on data from Census 
2010. The address of each active pharmacy was geocoded using ArcMap. The loca-
tion of each pharmacy was used to identify the nearest pharmacy to the centroid 
of each census block group. Independent variables included in the study were age, 
gender and race, the dependent variable was travel time to the nearest pharmacy 
from the centroid of each block group. RESULTS: As of November 2014, there were 
173 active community and hospital pharmacies in Hamilton County. Ninety three 
percent of the population had at least one pharmacy within a 5 minute drive time. 
Travel time was 2.57 minutes for whites, 1.96 minutes for blacks (p= 0.0016). Males 
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with selected chronic conditions, who were alive and had continuous fee-for-service 
enrollment through the observation period and were not enrolled in Medicare and 
had at least one inpatient encounter in the follow up period (N= 15,806). The depend-
ent variable, 30-day readmission was calculated in the follow-up year as those with 
an inpatient admission within 30-days from the discharge date of the first observed 
hospitalization. Multi-level logistic regressions that accounted for beneficiaries nested 
within counties was used to examine the factors associated with 30-day readmis-
sions. RESULTS: In this study population 16.7% had all-cause 30-day readmissions. 
Hispanics were less likely to have 30-day readmission as compared with Caucasians 
[AOR= 0.80, 95% CI 0.70,0.92]. Adults with asthma [AOR= 1.16, 95% CI 1.03,1.32], 
dementia [AOR= 1.44, 95% CI 1.10,1.87], and stroke [AOR= 1.38, 95% CI 1.07,1.78] were 
more likely to have 30-day readmission and those with cardiac arrhythmia [AOR 
= 0.82, 95% CI 0.68,0.99] and hypertension [AOR= 0.85, 95% CI 0.76,0.94] were less 
likely to have 30-day readmissions. Adults with greater lengths of stay during the 
index hospitalization were more likely to have 30-day readmissions [AOR = 1.03, 95% 
CI 1.03,1.04]. CONCLUSIONS: Patient-level factors were associated with the risk of 
30-day readmissions. Programs designed to reduce the risk of 30-day readmissions 
may need to focus on appropriate disease management.
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OBJECTIVES: (1) To determine the proportion of hospitals with and without imple-
mentation of electronic health records. (2) To examine characteristics of hospitals 
that report implementation of EHR partially or completely versus those hospitals 
that report no implementation. METHODS: The study is a retrospective cross-
sectional using the 2012 American Hospital Association Annual Survey database. 
The dependent variable was the implementation of EHR completely or partially, 
while hospital characteristics like staffing, organization structure, accredita-
tions, ownership, services and facilities provided formed independent variables. 
Descriptive frequencies was followed by multinomial logistic regression to deter-
mine variables independently associated with complete or partial implementation 
of EHR. RESULTS: 12.6% of hospitals reported no implementation of EHRs while 
43.9% and 43.5% of hospitals implemented EHRs partially and completely respec-
tively. Overall characteristics of hospitals with complete and partial implementation 
were similar. The multinomial regression model revealed that increase in number 
of licensed beds, type of service being children’s general medical and surgical and 
heart was associated with complete implementation of EHR. Inversely limited ser-
vice hospitals, hospitals participating in a network, psychiatric and rehabilitation 
service hospitals, government non-federal, nongovernment not-for-profit hospi-
tals showed less likelihood of complete implementation of EHR. CONCLUSIONS: 
Our findings suggest a possible disconnect between psychiatric and rehabilitation 
hospitals’ larger, for-profit hospitals and smaller, not-for-profit hospitals in EHR 
implementation. Policy initiatives need to particularly target these institutions to 
bridge this possible gap.
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OBJECTIVES: The objective of our study was to analyze the efficiency of the 
Hungarian outpatient care system between 2003 and 2013, and to define the tech-
nical (TE) and scale efficiency (SE) of them. METHODS: The analysis covered all the 
Hungarian outpatients care units (N= 539 in 2003, N= 514 in 2006, N= 475 in 2010, 
N= 494 in 2013). We used the Data Envelopment Analysis method for analysis, and 
chose the following variables: the weekly mean working hours of physicians and 
non-physicians (inputs), number of medical procedures, number of cases, number 
of the activity points and the reimbursement paid by the National Health Insurance 
Fund Administration (outputs).The outpatient units were classified into two groups: 
integrated with hospitals, or independent outpatient clinics. RESULTS: Technical 
efficiency of the integrated units was 51.6% in 2003, and it was continuously increas-
ing in the following years. Scale efficiency also improved after 2003 (started from 
38%, then +27.7% to 2006, decreased -0.8% to 2010, +8% to 2013). The independent 
units’ TE in 2003 started from 35.3%, the following years it changed with an aver-
age of +/- 1-2% only. SE in 2003 was 39.9%, with average increase of 5% in the fol-
lowing years. In this study we found an optimum capacity of 100-200 hours/week 
minimum, and 500-600 hours/week maximum limit for the integrated units, and 
60-100 hours/week minimum and 500 hours/week maximum for the independent 
units. CONCLUSIONS: Our study revealed that integrated outpatient units showed 
better efficiency rate than independent outpatient units. This analysis can give a 
starting point to the optimization of the Hungarian outpatient-care system. The 
efficiency scores can give guidelines to the analyzed units in order to become more 
efficient, but the system also needs a more detailed examination.
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the various shortcomings of such programs that were implemented before in order 
to prepare a good program that has taken into consideration all the factors that are 
necessary for the economic delivery of healthcare without excluding the quality 
oriented approach. It will also act as a model for private insurance firms or other 
organizations to adopt such a model in order to produce better outcomes at lower 
costs in the future. Therefore, if this model is revised and implemented properly 
it will be an economic solution to this problem of the unsustainable increase in 
healthcare costs of the U.S.
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OBJECTIVES: The availability of drugs in a market may affect patient care, health 
outcomes and costs. The objective of this study was to assess differences in the 
availability of human drugs marketed in the US and in Switzerland as of January 1, 
2015. METHODS: Information about all drugs approved in the US and Switzerland 
was derived from the Food and Drug Administration (FDA) and the Swiss Agency 
for Therapeutic Products (Swissmedic) respectively. The list of drugs reimbursed 
by the Swiss mandatory insurance was extracted from the Federal Office of 
Public Health. Drugs were classified according to the WHO anatomical therapeu-
tic chemical classification (ATC). Descriptive statistics and the chi-square test 
were performed. RESULTS: The FDA listed 2,491 different active ingredients and 
combinations (AICs) approved and marketed in the US, while the Swissmedic list 
contained 1,345 AICs. The US listed 138 orphan drug AICs of which 68.8% were 
listed by Swissmedic and 63.0% were included in the Swiss reimbursement list. 
Overall, 73% of the US AICs were listed by Swissmedic and 67% were reimbursed, 
while 29.8% AICs approved in Switzerland were not approved in the US. A statis-
tically significant (p < 0.05) higher percentage of non-orphan AICs marketed in 
the US than orphan AICs were listed by Swissmedic. ATC codes were available for 
94.8% of drugs approved by the FDA and 99.1% by Swissmedic. The nervous system 
was the ATC class with the highest proportion of US approved drugs marketed 
in Switzerland. CONCLUSIONS: Two-thirds of the AICs marketed in the US were 
marketed in the Swiss market. Orphan drugs have less presence in the Swiss than 
in the US market. Future research should compare the approval processes in both 
countries and evaluate the impact of the availability of drugs on patients’ outcomes 
and cost.
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OBJECTIVES: A comprehensive Feedlot Management System (FMS) was devel-
oped to optimize feedyard processes. The FMS consists of 43 Standard Operating 
Procedures. The objective of this study was to correlate consistent implementation 
of the FMS with better feeding performance based on Average Daily Gain and Dry 
Matter Conversion. METHODS: To evaluate the correlation of audit scoring consist-
ency to feeding performance, two databases were analyzed: audit scoring over a 
16 month interval which measures compliance with the FMS requirements, and 3 
years of feedlot closeout data. Audit scores from 1/2012-4/2013 were evaluated and 
a Consistency Index (CI) developed based on four criteria. Audits were converted 
to the CI, and an LSMeans calculated to rank 11 feedlots. For feedyard performance 
evaluation, a database of feedlot closeout records from 2011- 2013 was used, rep-
resenting 12,235,158 head and 97 feedlots. An index combining ADG and DmConv 
was developed utilizing a ratio of the FMS lot value to the average 3 year database 
value. To further account for variables outside control of management, a regression 
model was used with inputs from the database (86,772 lots). The model output was 
the Performance Index for each feedlot. The inputs were statistically significant 
at p< 0.001. R-squared = 0.443. The corresponding CI and Performance Index for 
each feedyard were analyzed using the Pearson correlation coefficient. RESULTS: 
The Feeding Performance Index and CI are highly correlated at 70%. The range of 
CI scores was larger in the lower scoring feedlots, indicating more variability. The 
aggregate LSMeans CI improved 20% over time. CONCLUSIONS: There are many fac-
tors that affect feeding performance in commercial beef cattle production, and this 
variability can result in unstable returns. In the study group of feedlots implement-
ing the FMS, consistency based on audit scoring was highly correlated to feeding 
performance. The study supports utilization of a comprehensive FMS, that optimizes 
processes and incorporates accountability.
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OBJECTIVES: Hospital readmissions, defined as 30-day post-discharge readmission, 
are used for assessing the performance of a healthcare system and are quality indica-
tors of patient care. This study examined the relationship between readmissions and 
patient- and county-level variables using multi-level analyses. METHODS: A retro-
spective cohort approach with a baseline and a follow-up period was used. Patient-
level data were derived from multi-state Medicaid claims for the period between 2006 
and 2008. County-level variables were derived from the Area Health Resource File of 
2007. The study cohort consisted of non-elderly (21-64 years) Medicaid beneficiaries 
